Purkinje cell cytoplasmic antibody type I (anti-Yo): predictive of gastrointestinal adenocarcinomas in men

J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1116-1117. doi: 10.1136/jnnp-2017-316829. Epub 2017 Nov 15.

Authors

Jenny Linnoila¹, Yong Guo², Avi Gadoth^{1

2}, Aditya Raghunathan², Becky Parks³, Andrew McKeon^{1

2}, Claudia F Lucchinetti¹, Vanda A Lennon^{1

2

4}, Sean J Pittock^{1

2}

Affiliations

¹ Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
² Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
³ Department of Neurology, Washington University, St Louis, Missouri, USA.
⁴ Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA.

PMID: 29142142
DOI: 10.1136/jnnp-2017-316829

No abstract available

Keywords: anti-yo; araneoplastic neurological autoimmunity.

Publication types

Case Reports
Letter

MeSH terms

Adenocarcinoma / diagnosis*
Adenocarcinoma / immunology
Aged
Autoantibodies*
Gastrointestinal Neoplasms / diagnosis*
Gastrointestinal Neoplasms / immunology
Humans
Male
Middle Aged
Nerve Tissue Proteins / immunology*

Substances

Autoantibodies
CDR2 protein, human
Nerve Tissue Proteins